<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01225601</url>
  </required_header>
  <id_info>
    <org_study_id>AOM 04141</org_study_id>
    <nct_id>NCT01225601</nct_id>
  </id_info>
  <brief_title>Prospective Evaluation of Adult Pulmonary Langerhans Cell Histiocytosis</brief_title>
  <acronym>LCHA1</acronym>
  <official_title>Epidemiology of Adult Adult Pulmonary Langerhans Cell Histiocytosis - A Multicenter Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - H么pitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - H么pitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study objectives:

        -  To estimate the incidence of pulmonary deterioration in adult pulmonary Langerhans cell
           histiocytosis

        -  To assess the impact of tobacco discontinuation

        -  Study Design Multicentric prospective cohort study

        -  Main endpoint: Pulmonary deterioration

        -  Sample size : 40 patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study objectives To estimate the incidence of pulmonary deterioration in adult pulmonary
      Langerhans cell histiocytosis To assess the impact of tobacco discontinuation Study Design
      Multicentric prospective cohort study Main endpoint: Pulmonary deterioration Sample size : 40
      patients
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pulmonary deterioration</measure>
    <time_frame>2 years</time_frame>
    <description>decrease in Forced expiratory volume in 1 second (FEV1), vital capacity (VC), or Diffusing capacity of the lung for carbon monoxide (DLCO) of at least 15% as compared to baseline values and/or progression of clinical symptoms (general symptoms) and/or occurrence of pneumothorax</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evolution of pulmonary volumes (FEV1)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of pulmonary lesions in High Resolution Computed Tomography (HRCT)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">62</enrollment>
  <condition>Adult Pulmonary Langerhans Cell Histiocytosis</condition>
  <arm_group>
    <arm_group_label>Histocytosis</arm_group_label>
    <description>Adult with isolated pulmonary Langerhans cell histiocytosis (pulmonary LCH)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tabacco discontinuation</intervention_name>
    <description>Tabacco discontinuation</description>
    <arm_group_label>Histocytosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult Pulmonary Langerhans cell histiocytosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pulmonary Langerhans cell histiocytosis diagnosed within the past 48 months

        Exclusion Criteria:

          -  Age &lt; 18

          -  Deep pulmonary dysfunction (CPT&lt; 60%, FEV1&lt; 30%, DLCO&lt; 30%, partial pressure of oxygen
             in arterial blood (PaO2)&lt; 60mmHg)

          -  No informed consent or consent withdrawal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abdellatif TAZI, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - H么pitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>H么pital Saint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Tazi A, de Margerie C, Naccache JM, Fry S, Dominique S, Jouneau S, Lorillon G, Bugnet E, Chiron R, Wallaert B, Valeyre D, Chevret S. The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study. Orphanet J Rare Dis. 2015 Mar 14;10:30. doi: 10.1186/s13023-015-0249-2.</citation>
    <PMID>25887097</PMID>
  </results_reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2010</study_first_submitted>
  <study_first_submitted_qc>October 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2010</study_first_posted>
  <last_update_submitted>April 15, 2016</last_update_submitted>
  <last_update_submitted_qc>April 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Histiocytosis</mesh_term>
    <mesh_term>Histiocytosis, Langerhans-Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

